1. Home
  2. ABR vs AGIO Comparison

ABR vs AGIO Comparison

Compare ABR & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$7.35

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$29.62

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
AGIO
Founded
2003
2007
Country
United States
United States
Employees
653
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ABR
AGIO
Price
$7.35
$29.62
Analyst Decision
Hold
Buy
Analyst Count
5
8
Target Price
$10.30
$37.63
AVG Volume (30 Days)
3.7M
673.1K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
16.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,011,000.00
Revenue This Year
N/A
$71.05
Revenue Next Year
N/A
$163.65
P/E Ratio
$9.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.11
$22.24
52 Week High
$12.58
$46.00

Technical Indicators

Market Signals
Indicator
ABR
AGIO
Relative Strength Index (RSI) 41.21 58.23
Support Level $7.23 $26.48
Resistance Level $7.95 $30.90
Average True Range (ATR) 0.22 1.04
MACD -0.06 0.16
Stochastic Oscillator 2.22 67.96

Price Performance

Historical Comparison
ABR
AGIO

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: